Promotion of nitric oxide production: mechanisms, strategies, and possibilities
Frontiers in Physiology · 23.01.2025 · 16
DOI: 10.3389/fphys.2025.1545044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Physiology, online erschienen am 23.01.2025. Verfasst von Marcos Gonzalez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Des Moines University Medicine and Health Sciences, West Des Moines, IA, United States. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 352 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
The discovery of nitric oxide (NO) and the role of endothelial cells (ECs) in its production has revolutionized medicine. NO can be produced by isoforms of NO synthases (NOS), including the neuronal (nNOS), inducible (iNOS), and endothelial isoforms (eNOS), and via the non-classical nitrate-nitrite-NO pathway. In particular, endothelium-derived NO, produced by eNOS, is essential for cardiovascular health. Endothelium-derived NO activates soluble guanylate cyclase (sGC) in vascular smooth muscle cells (VSMCs), elevating cyclic GMP (cGMP), causing vasodilation. Over the past four decades, the importance of this pathway in cardiovascular health has fueled the search for strategies to enhance NO bioavailability and/or preserve the outcomes of NO’s actions. Currently approved approaches operate in three directions: 1) providing exogenous NO, 2) promoting sGC activity, and 3) preventing degradation of cGMP by inhibiting phosphodiesterase 5 activity. Despite clear benefits, these approaches face challenges such as the development of nitrate tolerance and endothelial dysfunction. This highlights the need for sustainable options that promote endogenous NO production. This review will focus on strategies to promote endogenous NO production. A detailed review of the mechanisms regulating eNOS activity will be first provided, followed by a review of strategies to promote endogenous NO production based on the levels of available preclinical and clinical evidence, and perspectives on future possibilities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and Pharmacology, Des Moines University Medicine and Health Sciences, West Des Moines, IA, United States.
Förderung
- NIAAA NIH HHS
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Gonzalez, M., Clayton, S., Wauson, E., Christian, D., & Tran, Q. K. (2025). Promotion of nitric oxide production: mechanisms, strategies, and possibilities. Frontiers in Physiology, 16. https://doi.org/10.3389/fphys.2025.1545044
Vancouver
Gonzalez M, Clayton S, Wauson E, Christian D, Tran QK. Promotion of nitric oxide production: mechanisms, strategies, and possibilities. Frontiers in Physiology. 2025;16. doi:10.3389/fphys.2025.1545044
BibTeX
@article{Gonzalez2025,
author = {Gonzalez, Marcos and Clayton, Sarah and Wauson, Eric and Christian, Daniel and Tran, Quang-Kim},
title = {Promotion of nitric oxide production: mechanisms, strategies, and possibilities},
journal = {Frontiers in Physiology},
year = {2025},
volume = {16},
doi = {10.3389/fphys.2025.1545044}
}
EUVIMED